China continues to make Indonesia one of the priority investment destinations for its companies wishing to go global and expand their investment in Indonesia.
Beijing (ANTARA) - Three Chinese companies have signed a letter of intent (LoI) for the purchase of products worth US$505 million, or about Rp7.1 trillion, from Indonesia.



Beijing Huiyu Import-Export Co Ltd, Hebei Jinyezi Pharmaceutical Co Ltd, and Prestige International Trading Company Ltd signed the LoI on the sidelines of a business forum organized by the Indonesian Embassy in Beijing on Wednesday.



This is a special achievement considering this was the first time the embassy organized a hybrid offline-online event amid the COVID-19 pandemic, Indonesian Ambassador to China, Djauhari Oratmangun, said on Thursday.



Chinese investment in Indonesia rose 6 percent in the January-September period this year compared to the same period last year, he said, without elaborating on the value of investment.



"China continues to make Indonesia one of the priority investment destinations for its companies wishing to go global and expand their investment in Indonesia," he remarked.



The forum featured chief of the Indonesian Investment Coordinating Board (BKPM), Bahlil Lahadalia, chief representative of Bank Indonesia in Beijing, Arief Hartawan, and Secretary General of China Top 500, Huang Jun.



On Wednesday night, the embassy hosted a diplomatic reception to mark the 75th anniversary of Indonesian independence, which was attended by Assistant to Chinese Foreign Minister, Wu Jianghua, and representatives from friendly countries. (INE)


Related news: Indonesian investment board ready to facilitate relocation of Chinese firms

Related news: PM Li urges Chinese firms to prioritize Indonesian workers




EDITED BY INE

Translator: M. Irfan Ilmie/Suharto
Editor: Fardah Assegaf
Copyright © ANTARA 2020